Glycopyrronium Bromide API Manufacturers | Suppliers | Exporters

01

Inke S.A

Spain

Rescon USA Summit

Exhibiting

Inke S.A: APIs manufacturing plant.

Contact Supplier

Spain

Virtual Booth

Digital Content

Glycopyrronium Bromide

About the Company : Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse the...

Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation.

02

LGM Pharma

U.S.A

BioFlorida Conference

Attending

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

Glycopyrronium Bromide

About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...

LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, analytical method development and testing, and commercial manufacturing. LGM Pharma offers custom API synthesis, analytical development, and regulatory services. With a network of over 300 accredited CGMP manufacturing partners, LGM provides unparalleled supply chain security. And, with over 100,000 square feet of FDA-inspected cGMP manufacturing and warehouse capacity, LGM Pharma provides a one-stop solution for solid dose, powder, semi-solid and liquid drugs.

03

Seqens

France

2024 ACI Convention

Not Confirmed

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

France

Virtual Booth

Digital Content

Glycopyrronium Bromide

About the Company : Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling ...

Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. It offers a large portfolio of APIs and proprietary products. Seqens also develops custom solutions and ingredients for the most demanding industries, such as healthcare, electronics and cosmetics. Its unique range of technologies enables it to manufacture complex molecules for small- and large-scale demands. It operates 24 industrial plants and 10 R&D centres across the globe.

04

Jai Radhe Sales

India

CPhI India 2024

Attending

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

India

Virtual Booth

Digital Content

Glycopyrronium Bromide

About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...

Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete sourcing solutions for pharmaceutical products from India, including technical and regulatory assistance. It believes in providing its customers with high-quality products at reasonable prices. It has always endeavored to achieve global standards in the field of pharmaceuticals and has carved out a niche for itself through new methods based on current market needs. Today, it has established itself as a truly global company, with exports to almost every continent.

Product Web Link

05

Vamsi Labs

India

CPhI India 2024

Booth #2.D31

Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

Contact Supplier

India

Virtual Booth

Digital Content

Glycopyrronium Bromide

About the Company : Vamsi Labs, established in 1991, is a leading Indian API manufacturer. Specializing in anti-asthmatic, anti-migraine & anti-psychotic APIs, it caters to domestic & international ma...

Vamsi Labs, established in 1991, is a leading Indian API manufacturer. Specializing in anti-asthmatic, anti-migraine & anti-psychotic APIs, it caters to domestic & international markets(50% sales). Anti-asthma products account for 60% of sales. Vamsi adheres to high corporate governance, transparency, professionalism, & environmental protection standards. It's USFDA & EDQM certified & ISO 9001:2015, ISO 14001:2015, & ISO 45001:2018 certified. With a DSIR-certified R&D Lab, Vamsi continues to innovate & meet the pharma industry's evolving needs. Vamsi is poised to grow its globally while maintaining commitment to excellence and sustainability.

06

Balaji Corporation

India

India

2024 ACI Convention

Not Confirmed

Resonance Laboratories Pvt. Ltd

India

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

India

Virtual Booth

Digital Content

Glycopyrrolate

About the Company : Resonance has been a presence in the API and Specialty Chemicals segment for more than 30 years. After a start in Mumbai, operations moved to Bangalore in 1984. In the 30 years, Re...

Resonance has been a presence in the API and Specialty Chemicals segment for more than 30 years. After a start in Mumbai, operations moved to Bangalore in 1984. In the 30 years, Resonance has partnered with several multinationals on custom synthesis projects and with our strengths in multi-step synthesis together with focus on quality, we have helped our customers develop their products in a timely fashion. We have brought the same discipline to our API business and in the recent years have developed some complex molecules that are produced in our cGMP plant. Our facility is WHO GMP certified and we follow cGMP as per the ICH Q7 guideline.We have registered DMFs and CEPs for some of our products and are in the process of registering more. We currently sell to the European and other markets on the basis of our DMFs and CEPs.

Portfolio PDF

Product Web Link

India

2024 ACI Convention

Not Confirmed

Glycopyrronium Bromide

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

47 API Suppliers

23 USDMF

9 CEP/COS

2 JDMF

6 EU WC

5 KDMF

20 NDC API

30 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

33 Drugs in Development

FINISHED DOSAGE FORMULATIONS

147 FDF Dossiers

86 FDA Orange Book

22 Europe

13 Canada

1 Australia

7 South Africa

18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 1MG

TABLET;ORAL - 2MG

INJECTABLE;INJECTION - 0.2MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

POWDER;INHALATION - 15.6MCG/INH

POWDER;INHALATION - 15.6MCG/INH;27.5MCG/INH

SOLUTION;INHALATION - 25MCG/ML

TABLET, ORALLY DISINTEGRATING;ORAL - 1.7MG

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc

6 SPI Pharma

1 DKSH

4 Boai NKY Pharmaceuticals Ltd

13 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

8 Actylis

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

10 BASF

6 DFE Pharma

3 Finar

5 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

3 Ingredion Pharma Solutions

27 Kerry

12 Microlex e.U

1 Nippon Fine Chemical

1 Novo Excipients

3 Pharmatrans-Sanaq

5 Pluviaendo

3 Prachin Chemical

26 Roquette

1 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

10 Sigachi Industries

2 Ulanqab Kema New Material

1 Valens Pharmachem

3 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

72 Fillers, Diluents & Binders

33 Direct Compression

20 Disintegrants & Superdisintegrants

19 Co-Processed Excipients

16 Granulation

15 Thickeners and Stabilizers

15 Parenteral

14 Film Formers & Plasticizers

12 Lubricants & Glidants

11 Taste Masking

11 Solubilizers

10 Controlled & Modified Release

10 Coating Systems & Additives

7 Chewable & Orodispersible Aids

INJECTABLE;INJECTION - 0.2MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons